203 related articles for article (PubMed ID: 23707408)
1. Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
Bernardes A; Souza PC; Muniz JR; Ricci CG; Ayers SD; Parekh NM; Godoy AS; Trivella DB; Reinach P; Webb P; Skaf MS; Polikarpov I
J Mol Biol; 2013 Aug; 425(16):2878-93. PubMed ID: 23707408
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of allosteric communication in the human PPARalpha-RXRalpha heterodimer.
Venäläinen T; Molnár F; Oostenbrink C; Carlberg C; Peräkylä M
Proteins; 2010 Mar; 78(4):873-87. PubMed ID: 19847917
[TBL] [Abstract][Full Text] [Related]
3. Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.
Cho MC; Lee S; Choi HS; Yang Y; Tae Hong J; Kim SJ; Yoon DY
Immunopharmacol Immunotoxicol; 2009; 31(3):459-67. PubMed ID: 19263263
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
[TBL] [Abstract][Full Text] [Related]
5. Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ.
dos Santos JC; Bernardes A; Giampietro L; Ammazzalorso A; De Filippis B; Amoroso R; Polikarpov I
J Struct Biol; 2015 Sep; 191(3):332-40. PubMed ID: 26185032
[TBL] [Abstract][Full Text] [Related]
6. Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.
Yamamoto Y; Takei K; Arulmozhiraja S; Sladek V; Matsuo N; Han SI; Matsuzaka T; Sekiya M; Tokiwa T; Shoji M; Shigeta Y; Nakagawa Y; Tokiwa H; Shimano H
Biochem Biophys Res Commun; 2018 May; 499(2):239-245. PubMed ID: 29567478
[TBL] [Abstract][Full Text] [Related]
7. PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms.
Reichenbach G; Starzinski-Powitz A; Sloane BF; Doll M; Kippenberger S; Bernd A; Kaufmann R; Meissner M
Angiogenesis; 2013 Jan; 16(1):223-33. PubMed ID: 23096928
[TBL] [Abstract][Full Text] [Related]
8. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
[TBL] [Abstract][Full Text] [Related]
9. Comparison of full-length versus ligand binding domain constructs in cell-free and cell-based peroxisome proliferator-activated receptor alpha assays.
Berbaum J; Harrison RK
Anal Biochem; 2005 Apr; 339(1):121-8. PubMed ID: 15766718
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T
Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759
[TBL] [Abstract][Full Text] [Related]
11. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.
Capelli D; Cerchia C; Montanari R; Loiodice F; Tortorella P; Laghezza A; Cervoni L; Pochetti G; Lavecchia A
Sci Rep; 2016 Oct; 6():34792. PubMed ID: 27708429
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.
Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H
J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225
[TBL] [Abstract][Full Text] [Related]
14. [PPARα-Ligand Binding Modes Revealed by X-ray Crystallography].
Kamata S; Ishii I
Yakugaku Zasshi; 2021; 141(11):1267-1274. PubMed ID: 34719550
[TBL] [Abstract][Full Text] [Related]
15. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.
Cronet P; Petersen JF; Folmer R; Blomberg N; Sjöblom K; Karlsson U; Lindstedt EL; Bamberg K
Structure; 2001 Aug; 9(8):699-706. PubMed ID: 11587644
[TBL] [Abstract][Full Text] [Related]
16. The conserved residue Phe273(282) of PPARalpha(gamma), beyond the ligand-binding site, functions in binding affinity through solvation effect.
Yue L; Ye F; Xu X; Shen J; Chen K; Shen X; Jiang H
Biochimie; 2005 Jun; 87(6):539-50. PubMed ID: 15935279
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPARα and PPARγ.
Umemoto T; Fujiki Y
Genes Cells; 2012 Jul; 17(7):576-96. PubMed ID: 22646292
[TBL] [Abstract][Full Text] [Related]
19. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
Gani OA
Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
Molnár F; Matilainen M; Carlberg C
J Biol Chem; 2005 Jul; 280(28):26543-56. PubMed ID: 15888456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
